AREDS

Bausch + Lomb Launches PreserVision® AREDS 2 Formula Soft Gels Plus CoQ10 in the United States

Retrieved on: 
Monday, June 12, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of PreserVision® AREDS 2 Formula soft gels plus coenzyme Q10 (CoQ10).

Key Points: 
  • Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. launch of PreserVision® AREDS 2 Formula soft gels plus coenzyme Q10 (CoQ10).
  • Developed as a convenient two-in-one option, PreserVision AREDS 2 Formula eye vitamins plus CoQ10 is the only eye vitamin that combines the exact nutrient formula recommended by the National Eye Institute (NEI) to help reduce the risk of moderate to advanced Age-related Macular Degeneration (AMD) progression in AMD patients with CoQ10 to help support heart health.
  • AMD patients should also take an eye vitamin with the proven nutrient formula such as PreserVision® AREDS 2 vitamins to help reduce the risk of moderate to advanced AMD progression.
  • This product is not intended to diagnose, treat, cure or prevent any disease.

Bausch + Lomb Introduces Enhanced PreserVision® AREDS 2 Formula Mini Soft Gels with OCUSorb™

Retrieved on: 
Monday, January 9, 2023

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision® AREDS 2 Formula mini soft gels with OCUSorb™.

Key Points: 
  • Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, today announced the U.S. introduction of PreserVision® AREDS 2 Formula mini soft gels with OCUSorb™.
  • This product is the only AREDS 2 eye vitamin with the OCUSorb formulation.
  • I am pleased to recommend this new enhanced formula to my patients.”‡*
    PreserVision® AREDS 2 Formula eye vitamins, including the new OCUSorb formula, contain the exact nutrient formula recommended by the National Eye Institute (NEI).
  • “We remain committed to supporting and providing the nearly 16 million Americans affected by AMD with products that address their eye health needs.”
    PreserVision AREDS 2 Formula mini soft gels with OCUSorb are now available at most major retailers nationwide in the vitamin aisle or online and will replace the current PreserVision AREDS 2 Formula mini gel formula.

BAUSCH + LOMB AND PREVENT BLINDNESS LAUNCH ANNUAL AMD AWARENESS MONTH CAMPAIGN TO EDUCATE PATIENTS

Retrieved on: 
Tuesday, February 1, 2022

BRIDGEWATER, N.J. and CHICAGO, Feb. 1, 2022 /PRNewswire/ -- Bausch + Lomb, a leading global eye health business of Bausch Health Companies, Inc., and Prevent Blindness, the nation's oldest volunteer eye health non-profit organization, today announced they are joining together for the seventh consecutive year during AMD Awareness Month to share education and raise greater awareness of Age-Related Macular Degeneration (AMD), a leading cause of vision loss in adults 50 years and older that affects approximately 16 million people in America1.

Key Points: 
  • "Over the past several years, our AMD Awareness month campaign has raised $225,000 in support of Prevent Blindness' sight-saving fund, which helps identify and remove eye care barriers for patients, including those with AMD,"said Joe Gordon, U.S. president, Bausch + Lomb.
  • Bausch + Lomb will also donate $1* to Prevent Blindness and its sight-saving fund for every "like" or "share" of designated social media posts from the Bausch + Lomb SightMatters Facebook pageat https://www.facebook.com/SightMattersCommunity .
  • "Together with Bausch + Lomb, we look forward to making a positive impact in educating the public on AMD, as well as reminding everyone of the importance of healthy vision."
  • *Bausch + Lomb will donate$1to the organization Prevent Blindness for every Facebook like or share, up to$50,000from2/1/2022 through 2/28/2022.